These results suggest that modulation of mTOR, PI3K/Akt or AMPK signaling pathway with kinase inhibitors or activator is an effective strategy to block stemness and increase the chemosensitity of pancreatic cancer cells. Here, AKT1 is linked to pancreatic neoplasm.